Aligos Therapeutics, Inc.

NasdaqCM:ALGS Stock Report

Market Cap: US$68.7m

Aligos Therapeutics, Inc. Company Information

Aligos Therapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Aligos Therapeutics, Inc.
  • Ticker: ALGS
  • Exchange: NasdaqCM
  • Founded: 2018
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$68.664m
  • Shares Outstanding: 3.71m
  • Website: https://www.aligos.com

Number of Employees

Location

  • Aligos Therapeutics, Inc.
  • One Corporate Drive
  • 2nd Floor
  • South San Francisco
  • California
  • 94080
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ALGSNasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDOct 2020
5WK0DB (Deutsche Boerse AG)YesCommon StockDEEUROct 2020

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/20 19:17
End of Day Share Price 2024/11/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.